After hitting combined Sovaldi and Harvoni revenues of just over ... task given the total infected individuals number around 400 million. This tactic would be warmly welcomed by Gilead and its ...

Other companies such as Intercept, Allergan and Gilead have FXR agonists in their pipelines, but Hughes states that the potency of LJN452 is ‘200-400-fold ... by Gilead’s Sovaldi (sofosbuvir ...

Valley National Bancorp $9.55 0.44 4.83% ...

Each day, BD+C's editors assemble the latest breaking industry news, hottest trends, and most relevant research, delivered to your inbox.

Future Virology. 2015;10(1):53-61. The prevalence of HIV and HBV infections has been investigated in an international cohort of dental hygienists, and the conclusions were that these HCW had a ...

The definition and clinical use of common HBV serological markers are shown in Table 2. HBsAg is the hallmark of HBV infection and is the first serological marker to appear in acute hepatitis B ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...